This inventor holds 2 USPTO granted patents. Top assignees: Viropharma Incorporated, Wyeth. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 23 
2 out of 1,309 
Years Active: 2007-2010
Title: **Inventor Profile: Bheemashankar A Kulkarni**
Introduction
Bheemashankar A Kulkarni is a prominent inventor based in Exton, Pennsylvania, with a significant contribution to the field of pharmaceutical innovations. He holds a total of two patents that focus on the treatment and prophylaxis of hepatitis C viral infections and associated diseases. His work demonstrates a dedication to advancing medical science through innovative solutions.
Latest Patents
Kulkarni's latest patents involve novel benzofuran compounds, derivatives, and analogs, which are aimed at providing effective treatments for hepatitis C. His inventions not only propose methods for addressing hepatitis C viral infections but also include compositions specifically designed for treatment and prevention. The essence of these patents revolves around benzofuran derivatives, showcasing their potential in combating viral infections and their associated diseases.
Career Highlights
Throughout his career, Bheemashankar A Kulkarni has worked with notable companies such as Viropharma Incorporated and Wyeth. His experiences in these organizations have undoubtedly helped shape his innovative ideas and contribute to his patent portfolio. Kulkarni’s work has established him as a key figure in the pharmaceutical innovation landscape.
Collaborations
In his professional journey, Kulkarni has collaborated with talented individuals, including Ashis Kumar Saha and Christopher J Burns. These collaborations highlight the importance of teamwork and shared knowledge in the pursuit of groundbreaking inventions within the field of pharmaceuticals.
Conclusion
Bheemashankar A Kulkarni's contributions to the field of pharmaceutical innovations, particularly through his patents on benzofuran compounds for hepatitis C, reflect his commitment to enhancing treatment options for viral infections. His career and collaborations demonstrate the significance of teamwork in the realm of inventions, ultimately aiming to improve health outcomes globally.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile